Valentina Robustelli

431 total citations
13 papers, 103 citations indexed

About

Valentina Robustelli is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Valentina Robustelli has authored 13 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Molecular Biology. Recurrent topics in Valentina Robustelli's work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Valentina Robustelli is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Valentina Robustelli collaborates with scholars based in Italy and United States. Valentina Robustelli's co-authors include Cristina Papayannidis, Giovanni Martinelli, Chiara Sartor, Stefania Paolini, Anna Ferrari, Andrea Ghelli Luserna di Rorà, Viviana Guadagnuolo, Maria Chiara Abbenante, Sarah Parisi and Giovanni Marconi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Valentina Robustelli

13 papers receiving 103 citations

Peers

Valentina Robustelli

ONCOL

HEMAT

PHEOH

Stephanie Nance United States

Claudia Lanauze United States

André Bortolini Silveira Brazil

Laurène Fenwarth France

Guillaume Hypolite France

Alice Piapi United Kingdom

Elen Oliveira Brazil

Olga Zimmermannová Sweden

Valeria Cazzaniga Italy

Martina Mijušković United Kingdom

Stephanie Nance United States

Valentina Robustelli

73 ×1.2

21 ×0.5

ONCOL

20 ×0.5

HEMAT

26 ×0.9

PHEOH

13 ×1.0

Citations per year, relative to Valentina Robustelli Valentina Robustelli (= 1×) peers Stephanie Nance

Countries citing papers authored by Valentina Robustelli

Since Specialization

Citations

This map shows the geographic impact of Valentina Robustelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Robustelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Robustelli more than expected).

Fields of papers citing papers by Valentina Robustelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Robustelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Robustelli. The network helps show where Valentina Robustelli may publish in the future.

Co-authorship network of co-authors of Valentina Robustelli

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Robustelli. A scholar is included among the top collaborators of Valentina Robustelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Robustelli. Valentina Robustelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Corradi, Giulia, Dorian Forte, Marilena Ciciarello, et al.. (2024). Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells. Frontiers in Immunology. 15. 1386517–1386517. 5 indexed citations

Sartor, Chiara, Mario Arpinati, Gabriella Chirumbolo, et al.. (2022). Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment. Hematological Oncology. 40(4). 734–742. 4 indexed citations

Bruno, Samantha, Valentina Robustelli, Claudia Venturi, et al.. (2021). Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia. Frontiers in Oncology. 11. 728613–728613. 5 indexed citations

Simonetti, Giorgia, Elisabetta Petracci, Eugenio Fonzi, et al.. (2021). Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia. Frontiers in Oncology. 11. 9 indexed citations

Papayannidis, Cristina, Chiara Sartor, Alida Dominietto, et al.. (2020). ALL-073: Inotuzumab Ozogamicin (IO) and Donor Lymphocyte Infusion (DLI) are a Safe and Promising Combination in Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT). Clinical Lymphoma Myeloma & Leukemia. 20. S161–S161. 1 indexed citations

Rorà, Andrea Ghelli Luserna di, Anna Ferrari, Carolina Terragna, et al.. (2019). Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia. Cancers. 11(11). 1654–1654. 22 indexed citations

Bertamini, Luca, Jacopo Nanni, Giovanni Marconi, et al.. (2018). Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia. BMC Cancer. 18(1). 16 indexed citations

Rorà, Andrea Ghelli Luserna di, Anna Ferrari, Valentina Robustelli, et al.. (2017). Enhance the Efficacy of Doxorubicin Destabilizing the G2/M Checkpoint with a CHK1/CHK2 Inhibitor Pre-Treatment on Acute Lymphoblastic Leukemia. Blood. 130. 5049–5049. 1 indexed citations

Marconi, Giovanni, Maria Chiara Fontana, Cristina Papayannidis, et al.. (2017). Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia.. Journal of Clinical Oncology. 35(15_suppl). 7038–7038. 2 indexed citations

10.

Rorà, Andrea Ghelli Luserna di, Ilaria Iacobucci, Enrico Derenzini, et al.. (2016). Abstract 2723: The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia. Cancer Research. 76(14_Supplement). 2723–2723. 1 indexed citations

11.

Rorà, Andrea Ghelli Luserna di, Ilaria Iacobucci, Cristina Papayannidis, et al.. (2016). Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia. Oncotarget. 7(33). 53377–53391. 29 indexed citations

12.

Padella, Antonella, Giorgia Simonetti, Anna Ferrari, et al.. (2015). RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia. Blood. 126(23). 3627–3627. 1 indexed citations

13.

Ferrari, Anna, Cristina Papayannidis, Carmen Baldazzi, et al.. (2014). Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome. Blood. 124(21). 2379–2379. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact